Agilent acquires Stratagene
Agilent Technologies has announced the acquisition of the company Stratagene, effective as of today.
The takeover is hoped to assist the company in providing more complete workflow solutions in genomics, proteomics and metabolomics.
Stratagene will operate as a division of the company's Life Sciences Solutions unit.
The company has said current customers should expect no change in the way they work with Stratagene and should be able to continue using their existing contact channels.
Australian Healthcare Week 2024: register for your free pass
With more than 150 leading health sector speakers, over 100 sessions and two deep-dive master...
Recommendations released: Pathway to Diversity in STEM Review
The Pathway to Diversity in STEM Review addresses the urgent need for Australia to boost its STEM...
Built for the future: KAESER Australia unveils new facility in Vic
The 4500 m2, $15 million facility features various innovations that echo KAESER's...